Octapharma AB
🇸🇪Sweden
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
19
CIMA_AEMPS:8
NMPA:6
EMA:2
+2 more agencies
Drug Approvals
Recombinant Human Coagulation Factor Ⅷ for Injection
- Product Name
- 凝唯
- Approval Number
- 国药准字SJ20240036
- Approval Date
- Aug 13, 2024
NMPA
Recombinant Human Coagulation Factor Ⅷ for Injection
- Product Name
- 凝唯
- Approval Number
- 国药准字SJ20240037
- Approval Date
- Aug 13, 2024
NMPA
Recombinant Human Coagulation Factor Ⅷ for Injection
- Product Name
- 凝唯
- Approval Number
- 国药准字SJ20240038
- Approval Date
- Aug 13, 2024
NMPA
Recombinant Human Coagulation Factor Ⅷ for Injection
- Product Name
- 凝唯
- Approval Number
- 国药准字SJ20240039
- Approval Date
- Aug 13, 2024
NMPA
Clinical Trials
No trials found
News
No news found